Results 201 to 210 of about 123,913 (326)

Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?

British Journal of Pharmacology, EarlyView.
Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli, Emanuela Micioni Di Bonaventura, Giacomo Einaudi, Gustavo Provensi, Alessia Costa, Claudio D'Addario, Carlo Cifani, Maria Vittoria Micioni Di Bonaventura   +7 more
wiley   +1 more source

Dopamine agonist responsive burning mouth syndrome: Report of eight cases. [PDF]

World J Clin Cases, 2021
Du QC, Ge YY, Xiao WL, Wang WF.
europepmc   +1 more source

Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions [PDF]

, 1987
JM Trugman, GF Wooten
openalex   +1 more source

Ultra‐processed food addiction: A growing international concern

Addiction, EarlyView.
Laura A. Schmidt
wiley   +1 more source

Sex‐specific impact of repeated adolescent vapour exposure to JWH‐018 on dopamine response, behaviour and pharmacokinetics across adolescence and adulthood

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Alarming trends show that vaping e‐cigarettes containing synthetic cannabinoid receptor agonists, such as JWH‐018, is increasing among youth. However, the effects of these trends are unclear in both sexes. We therefore characterized the neuropharmacological effects of adolescent JWH‐018 inhalation in male and female rats.
Nicholas Pintori, Cristina Manis, Enrica Spano, Nicola Simola, Alessandro Ieraci, Pierluigi Caboni, Gaetano Di Chiara, Maria Antonietta De Luca   +7 more
wiley   +1 more source

Study of Clinical Profile and Early Response to Dopamine Agonist Therapy in Patients of Hyperprolactinemia: Experience at a Tertiary Care Centre of Nepal. [PDF]

Indian J Endocrinol Metab
Nepal R, Bajracharya MR, Karki BB, Adhikari BBS, Wasti KP, Bisht A.   +5 more
europepmc   +1 more source

Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management? [PDF]

Endocr Oncol, 2022
De Sousa SMC.
europepmc   +1 more source

Effects of dopamine and selective dopamine agonists upon platelet accumulation in the cerebral and pulmonary vasculature of the rabbit [PDF]

, 1997
Michael Emerson, William Paul, Pierpaolo Ferlenga, C. Semeraro, Clive Page   +4 more
openalex   +1 more source

3,4‐Methylenedioxymethamphetamine (MDMA) does not induce robust psychomotor activation and 50‐kHz ultrasonic vocalisations in tryptophan hydroxylase 2 (Tph2)‐deficient rats lacking serotonin in the central nervous system

British Journal of Pharmacology, EarlyView.
Background and Purpose 3,4‐Methylenedioxymethamphetamine (MDMA), commonly known as ecstasy, is a psychostimulant with entactogenic properties and known to induce arousal and euphoria. As an amphetamine derivate, MDMA acts on the monoamine systems in the brain and stimulates release of dopamine (DA), noradrenaline (NA) and serotonin (5‐HT), yet their ...
Tianhua Wang, Rainer K. W. Schwarting, Markus Wöhr   +2 more
wiley   +1 more source

Dopamine agonist treatment normalizes neck motor dyscoordination and relieves pain in chronic tension-type headache and common whiplash. A pilot study. [PDF]

Pain Manag
Astrup J, Gyntelberg F, Olesen J.
europepmc   +1 more source